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Dementia is a degenerative neurological disease affecting 3.4 million people 
worldwide. The symptoms of the disease are debilitating to the patient causing the 
eventual inability to care for oneself. The current mainstay of treatment is with 
acetylcholinesterase inhibitors which aim to slow the progression of the disease. 
However, not only do these medications cause multiple side effects negatively 
impacting the patient’s quality of life, but they are only at best shown to provide mild 
stabilization of cognition. Music therapy as a novel method of treatment without 
negative side effects, is an alternative option to pharmacological therapy. This 
paper will address the efficacy of music therapy (I), in contrast to the standard of 
care (C), in improving the quality of life (O) of older adults with dementia (P).
Dementia
Overview
● Over 71→ prevalence is about 13.9% or 3.4 million individuals 
● Progressive neurological degenerative disease
● Growing elderly population with increased life expectancy
Symptoms
● Loss of memory and cognitive abilities
● Behavioral and psychological symptoms of dementia: depression, psychosis, 
agitation and aggressive behavior
Treatment
● First line treatments include acetylcholinesterase inhibitors and 
N-methyl-D-aspartate (NMDA) receptor antagonists























Music Therapy in the Treatment of Dementia
Key: RCT= randomized controlled trial, MA= meta-analysis, MT= music therapy, CI= cholinesterase inhibitor, QOL-AD= quality of life assessment, 
TMT-A= Trail Making Test Part A, CMAI-C= Cohen-Mansfield Agitation Inventory Scale, MMSE= mini-mental status exam, DRS= dementia rating 
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